Disabled PersonsRadiation DosageLethal Dose 50Time FactorsUnited StatesDrug Administration ScheduleAdministration, OralHomeless PersonsRadiometryTreatment OutcomeRisk FactorsMentally Ill PersonsVisually Impaired PersonsDouble-Blind MethodMentally Disabled PersonsDose-Response Relationship, RadiationHIV InfectionsDose FractionationRadiotherapy DosageAge FactorsIncidenceProspective StudiesInjections, IntravenousArea Under CurveCohort StudiesPrevalenceQuestionnairesFollow-Up StudiesHalf-LifeNeoplasmsInfusions, IntravenousRadiotherapy Planning, Computer-AssistedPopulation SurveillanceSex FactorsCross-Sectional StudiesDisease OutbreaksBody BurdenDrug Therapy, CombinationRetrospective StudiesDrug InteractionsThermoluminescent DosimetryAnalysis of VarianceRadiation MonitoringLongitudinal StudiesRats, Sprague-DawleyAgingRisk AssessmentBiological AvailabilityRelative Biological EffectivenessAge DistributionAntineoplastic AgentsRadiation InjuriesInjections, SubcutaneousReproducibility of ResultsMetabolic Clearance RateChronic DiseaseMetered Dose InhalersInfant, NewbornBlood PressureBody WeightAcquired Immunodeficiency SyndromeSeverity of Illness IndexDrug EvaluationDrug CombinationsLiverSingle PersonRegression AnalysisSocioeconomic FactorsHealth StatusRiskInjections, IntramuscularRadiotherapy, Intensity-ModulatedDisease Models, AnimalDementiaPregnancyRats, WistarLogistic ModelsHealth SurveysAntineoplastic Combined Chemotherapy ProtocolsImmunization ScheduleSex DistributionRandom AllocationQuality of LifeGeriatric AssessmentAntibodies, ViralPersonhoodInfluenza VaccinesAdministration, InhalationBrainPhantoms, ImagingDogsSpinal Cord InjuriesFecesPlacebosInjections, IntraperitonealMotor ActivityHospitalizationSensitivity and SpecificityPainRadioisotopes